11-46875564-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_002334.4(LRP4):c.3817C>A(p.Arg1273=) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,614,078 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 22 hom. )
Consequence
LRP4
NM_002334.4 synonymous
NM_002334.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 8.13
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 11-46875564-G-T is Benign according to our data. Variant chr11-46875564-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211405.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0036 (548/152206) while in subpopulation NFE AF= 0.00503 (342/68008). AF 95% confidence interval is 0.00459. There are 1 homozygotes in gnomad4. There are 321 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 22 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP4 | NM_002334.4 | c.3817C>A | p.Arg1273= | synonymous_variant | 27/38 | ENST00000378623.6 | NP_002325.2 | |
LRP4 | XM_017017734.2 | c.3817C>A | p.Arg1273= | synonymous_variant | 27/39 | XP_016873223.1 | ||
LRP4 | XM_011520103.3 | c.3013C>A | p.Arg1005= | synonymous_variant | 21/32 | XP_011518405.1 | ||
LRP4 | XM_011520104.3 | c.1582C>A | p.Arg528= | synonymous_variant | 12/23 | XP_011518406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP4 | ENST00000378623.6 | c.3817C>A | p.Arg1273= | synonymous_variant | 27/38 | 1 | NM_002334.4 | ENSP00000367888 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00360 AC: 548AN: 152088Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
548
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00403 AC: 1012AN: 251250Hom.: 8 AF XY: 0.00415 AC XY: 563AN XY: 135778
GnomAD3 exomes
AF:
AC:
1012
AN:
251250
Hom.:
AF XY:
AC XY:
563
AN XY:
135778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00291 AC: 4251AN: 1461872Hom.: 22 Cov.: 35 AF XY: 0.00301 AC XY: 2188AN XY: 727236
GnomAD4 exome
AF:
AC:
4251
AN:
1461872
Hom.:
Cov.:
35
AF XY:
AC XY:
2188
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00360 AC: 548AN: 152206Hom.: 1 Cov.: 32 AF XY: 0.00431 AC XY: 321AN XY: 74430
GnomAD4 genome
AF:
AC:
548
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
321
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | LRP4: BP4, BS2 - |
Cenani-Lenz syndactyly syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 13, 2017 | - - |
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at